title: Limiting "evergreening" for a better balance of drug innovation incentives.
authors.forename: Matthew B
authors.initials: MB
authors.lastname: Stanbrook
mesh_terms: D002170:Canada; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D015507:Drugs, Investigational; D014943:Global Health; D006801:Humans; D007880:Legislation, Drug; D009042:Motivation; D010330:Patents as Topic / Q000331:legislation & jurisprudence*
chemical_list: D016568:Drugs, Generic; D015507:Drugs, Investigational